Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects

导出原文传递

翻译打印收藏纠错

作者： Boof, Marie-Laure ^[1] ; Halabi, Atef ^[2] ; Ufer, Mike ; Dingemanse, Jasper

作者单位： Dept Clin Pharmacol, Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil ^[1] Clin Res Services Kiel GmbH, Lornsenstrasse 7, DE-24105 Kiel, Germany ^[2]

关键词 Lucerastat Fabry disease OCT2 Drug-drug interaction Pharmacokinetics

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

European journal of clinical pharmacology

2020年76卷3期

431-437页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects

European journal of clinical pharmacology

相似文献

European journal of clinical pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects

European journal of clinical pharmacology

相似文献

European journal of clinical pharmacology

相关期刊

检索历史清除